CDH13 and chronic myelogenous leukemia, BCR-ABL1 positive: Low expression of CDH13 has been observed in many cancers, including non-small cell lung cancer [5], nasopharyngeal cancer [6], esophageal cancer [7], ovarian cancer [8], CML [9, 10], acute myeloid leukemia [11], and breast cancer [12].